Results 161 to 170 of about 31,353 (262)
Neurodegenerative Tauopathies [PDF]
Neuron, 1999 Lee, Virginia M.-Y, Trojanowski, John Q
openaire +1 more source
Asymmetric Parietal Cortical Atrophy in a Patient with RAB39B‐Associated Parkinsonism
Movement Disorders Clinical Practice, Volume 13, Issue 2, Page 548-552, February 2026.
Luca Gallo +8 more
wiley +1 more source
Reply: “PGRN Manifesting as Parkinson's Disease: Counseling and Treatment Implications”
Movement Disorders Clinical Practice, Volume 13, Issue 2, Page 585-586, February 2026.
Angelo Antonini +2 more
wiley +1 more source
Implications of virus-induced stress granules in tauopathies. [PDF]
Transl NeurodegenerSharma S +4 more
europepmc +1 more source
Deep Learning-Based Classification of Temporal Stages of AT8-Labeled Tau Pathology After Experimental Traumatic Brain Injury. [PDF]
Neuroinformaticsde Antunes E Sousa GJ +5 more
europepmc +1 more source
, 2016 Neurodegenerative diseases, of which tauopathies form a major class, are increasing in prevalence worldwide. Tauopathies are characterized by the presence of abnormal neuronal and glial inclusions that are composed predominantly of the microtubule associated protein, tau. Several foci of increased incidence of tauopathies have been identified that have
openaire +1 more source
Advancing Alzheimer's research by improving disease modeling of secondary tauopathy. [PDF]
NPJ DementRoy ER, Cao W.
europepmc +1 more source
Gut Microbiome-Sphingolipid Metabolism-Brain Axis Interactions: Neuroprotective Effects of Amitriptyline as Functional Inhibitor of Acid Sphingomyelinase in a Mouse Model of Tauopathy. [PDF]
J Neuroimmune PharmacolIbrahim M +5 more
europepmc +1 more source